There is a great deal of talk in the press about Comparative Effectiveness Research -- both pro and con. On one end of the spectrum people fear that the government will mandate the cheapest possible treatment. On the other, physicians are worried that they and their patients are being swayed by the marketing hype generated by pharmaceutical companies while there is little evidence to prove that a new expensive treatment is significantly better than a tried-and-true modestly priced treatment. Tony Coelho, chairman of the Partnership to Improve Patient Care, visits with Joyce to talk about the issues surrounding this new initiative.

Note: Daddyteller session moved to Friday 1/15